The latest price target for LifeStance Health Gr (NASDAQ:LFST) was reported by UBS on August 15, 2024. The analyst firm set a price target for $7.50 expecting LFST to rise to within 12 months (a possible 10.13% upside). 8 analyst firms have reported ratings in the last year.

The latest analyst rating for LifeStance Health Gr (NASDAQ:LFST) was provided by UBS, and LifeStance Health Gr maintained their neutral rating.

The last upgrade for LifeStance Health Group Inc happened on January 6, 2023 when Morgan Stanley raised their price target to $8. Morgan Stanley previously had an equal-weight for LifeStance Health Group Inc.

The last downgrade for LifeStance Health Group Inc happened on March 17, 2022 when UBS changed their price target from $19 to $10 for LifeStance Health Group Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LifeStance Health Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LifeStance Health Gr was filed on August 15, 2024 so you should expect the next rating to be made available sometime around August 15, 2025.

While ratings are subjective and will change, the latest LifeStance Health Gr (LFST) rating was a maintained with a price target of $9.00 to $7.50. The current price LifeStance Health Gr (LFST) is trading at is $6.81, which is out of the analyst’s predicted range.